1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Apheresis Equipment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Disposable Apheresis Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Apheresis Machine
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Blood Collection
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Treatment
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Neurology
7.2.2.2 Hematology
7.2.2.3 Renal Diseases
7.2.2.4 Others
7.2.3 Market Forecast
8 Market Breakup by Procedure
8.1 Plasmapherasis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Plateletpherasis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Erythrocytapheresis
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Leukapheresis
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Photopheresis
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Technology
9.1 Membrane Filtration
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Centrifugation
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by End User
10.1 Blood Collection Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals and Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Asahi Kasei Corporation
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 B. Braun Melsungen Aktiengesellschaft
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 SWOT Analysis
16.3.3 Baxter International Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 SWOT Analysis
16.3.5 Haemonetics Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Hemacare Corporation (Charles River Laboratories, Inc.)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Kaneka Corporation
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Kawasumi Laboratories Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Medica SpA
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Nikkiso Co Ltd.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Terumo BCT Inc. (Terumo Corporation)
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 SWOT Analysis
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
